CORPORATE NEWS 27-NOV-2018

Cadila gets final USFDA approval for Baclofen Tablets

Cadila Healthcare has received a final approval from the US Food & Drug Administration (USFDA) to market Baclofen Tablets (US RLD- Lioresal®), 10 mg and 20 mg. Despite the news, shares of the company dropped 2% on Tuesday.

The company will produce Baclofen Tablets from its formulations manufacturing facility at Baddi. These tablets are used to treat muscle spasms caused by certain conditions such as multiple sclerosis, spinal cord injury/disease, the company said in a press note to the exchanges.

Tech Mahindra receives order worth Rs270cr from Coal India: Media report

Tech Mahindra has bagged an order worth Rs270cr for IT modernization project from Coal India, as per PTI report. Despite this, the company’s shares fell 0.68% today.

According to media report, an order includes supply and implementation of Hospital Information Management System, across all eight subsidiaries of Coal India covering 21 hospitals.

The company is expected to implement the project in phased manner. It will finish the work in five years. In the first phase the company will implement ERP software in Coal India and its two subsidiaries, Mahanadi Coalfields and Western Coalfields, the report said.

Alembic Pharma gets USFDA approval for Temazepam Capsules

Alembic Pharmaceuticals, in a filing to the exchanges on Tuesday, announced that it has received an approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Temazepam Capsules USP (7.5mg, 15mg, 22.5mg, and 40mg).

"The approved ANDA is therapeutically equivalent to the reference-listed drug product (RLD) Restoril Capsules (7.5mg, 15mg, 22.5mg, and 40mg), of SpecGx LLC. Temazepam Capsules are indicated for the short-term treatment of insomnia," the company said in a press note on Tuesday.

IFCI up 5% on Binani Cement’s case resolution under IBC

Shares of IFCI rose 5% on the news of resolution of Binani Cement’s case under the Insolvency and Bankruptcy Code (IBC).

IFCI received Rs491.84cr towards the security receipts held by it in Binani Cements. On account of resolution of Binani Cements through the National Company Law Tribunal (NCLT), IFCI, which holds 42,16,850 security receipts of face value of Rs1,000/- each, has received an amount of Rs.491.84cr, net of TDS of Rs30.55cr, pursuant to the said resolution.

Tata Chemicals enters Canada; signs deal with Univar

Ingredients distributor Univar has secured a deal with Tata Chemicals to take the Indian company’s fermented, digestive health ingredients to Canada. Tata NQ, the nutritional solutions division of Tata Chemicals, offers customers digestive health ingredients with benefits which aim to meet growing consumer nutritional trends.

With the above agreement, Univar will be the sole distributor of Tata NQ’s Fossence and Gossence prebiotic dietary fibre portfolio of ingredients for the Canadian market. These fibres are used in a range of applications, including dietary supplements, functional foods (bakery, dairy, snack foods), confectionery, and pet food. Fossence and Gossence are made using Tata NQ’s proprietary in-house fermentation technology in a manufacturing facility in India.

Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More

MARKET WRAP UP 27-NOV-2018

Closing Bell: Sensex ends 159 points higher, Nifty at 10,685; Infosys up 3%.

It’s a green close for the market on Tuesday, with the Nifty ending well above 10,650-mark.

A rally among PSU banks, energy names as well as IT boosted the market. In the broader market, the Nifty Midcap index ended over half a percent higher.

At the close of market hours, the Sensex ended up 159.06 points or 0.45% at 35513.14, while the Nifty was higher by 57.00 points or 0.54% at 10685.60. The market breadth was narrow as 1238 shares advanced, against a decline of 1320 shares, while 161 shares were unchanged.

Infosys, TCS, and BPCL were the top gainers, while Sun Pharma and Hero MotoCorp lost the most.

HEADLINES OF THE DAY

Punjab National Bank shares gained 2.5 per cent after the lender expects Rs 2,500 crore recovery from Essar Steel resolution.

Zydus Cadila gets USFDA approval: Zydus Cadila has received the final approval from the USFDA to market Baclofen Tablets, 10 mg and 20 mg. It will be manufactured at the group’s formulations manufacturing facility at Baddi.

Lupin gets EIR from USFDA: The company has received EIR (Establishment Inspection Report) on the completion of an inspection by the USFDA (United States Food & Drug Administration) at its facility in Tarapur, Maharashtra.

USFDA approves ANDA filed by Granules Pharma.

Jet Airways salary payment: PTI reported that Jet Airways will pay the remaining 25 per cent September salary to its senior staff early next month and is likely to come out with a revised payment schedule soon, a source at the airline said.

The crucial resistance for the Nifty spot is now seen at 10720 and above this 10920 Support for the immediate term is now placed at 10480 next support will be 10370.

Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More

CS OPENING BELL 27-NOV-2018

NIFTY SPOT down 14 @10613

SENSEX SPOT down 31 @35322

BANK NIFTY FUTURES down 58 @26407

HAPPY TRADING!

WWW.CAPITALSTARS.COM+919977499927

CS NIFTY FUTURES (NOV ) OVERVIEW

TREND BEARISH

RES2: 10810

RES 1:10700

SUP1:10550

SUP2:10400 

CS BANK NIFTY FUTURES (NOV ) OVERVIEW

TREND BULLISH

RES 2: 26660

RES 1: 26400

SUP1: 26100

SUP2: 25900 

Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More

Nifty likely to open flat 27-Nov-2018

A morning walk down Dalal Street | Volatility to continue in near term, really only possible if Nifty crosses 10,774.

Indian Indices:                           Experts expect the volatile movement to continue in near term. The rally is only possible if the Nifty crosses 10,774 levels.

Global Market:

·       Asian markets: Asian markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.45% while the Hang Seng is up 0.05%. The Shanghai Composite is not trading.

·       US Markets: Stock Market News: Indexes Mark Weak Close As Oil Prices Plunge.

·       European markets: European markets finished broadly higher today with shares in Germany leading the region. The DAX is up 1.45% while London's FTSE 100 is up 1.20% and France's CAC 40 is up 0.97%.

·       Major Headlines of the day:

·       Indian rupee opens flat at 70.89 per dollar.

·       IL&FS gets more than 12 expressions of interest to buy stake in 2 subsidiaries.

·       Results to be announced today:- RELCAPITAL.

·         Trend in FII flows:-  The FIIs were Net Value of Rs  62.74 segment while the DIIs were Net Value of  351.78 the provisional figures.

Securities in Ban For Trade Date 27-NOVEMBER-2018

1.Adanipower

2.Adanient

3.Jetairways

4.DHFl

Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More

MARKET WRAP-UP 26-NOV-2018

Closing Bell: Sensex closes 373 points higher, Nifty above 10,600; FMCG leads rally

Shares were off to a flying start on Monday, thanks to a sharp rally among consumption names in the last couple of hours

Among sectors, financials, automobiles, consumption, and IT names were in the green, while investors sold metals and pharmaceuticals segments. In the broader markets, Nifty Midcap index underperformed benchmarks but closed with gains of around 0.2 per cent.

At the close of market hours, the Sensex was up 373.06 points or 1.07% at 35354.08, while the Nifty ended higher by 101.80 points or 0.97% at 10628.60. The market breadth was negative as 1,080 shares advanced, against a decline of 1,508 shares, while 160 shares were unchanged.

Hero MotoCorp, Wipro, and HUL are the top gainers, while ONGC, Sun Pharma, and Yes Bank lost the most.

HEADLINES OF THE DAY

Lupin receives USFDA approval for Clomipramine HCL capsules

BEML bags order worth Rs3,015cr for Mumbai Metro

Alembic Pharma JV gets USFDA approval for Lidocaine ointment

The crucial resistance for the Nifty spot is now seen at 10700 and above this 10830 Support for the immediate term is now placed at 10500 next support will be 10440.

Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More

CORPORATE NEWS 26-NOV-2018

Lupin receives USFDA approval for Clomipramine HCL capsules

Pharma major Lupin has received USFDA approval for its Clomipramine Hydrochloride Capsules USP, 25 mg, 50 mg, and 75 mg, to market a generic version of SpecGx LLC’s Anafranil Capsules, 25 mg, 50 mg, and 75 mg.

It is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).

Anafranil Capsules, 25 mg, 50 mg, and 75 mg had annual sales of approximately $109.6mn in the US, as per IQVIA MAT September 2018 data.

BEML bags order worth Rs3,015cr for Mumbai Metro

Shares of BEML are up by 2% on the news that it has been awarded a Letter of Acceptance from DMRC for the supply of 378 metro coaches (63 metro trains) to Mumbai Metro Line - 2 & 7 projects.

The contract is worth ~Rs3, 015cr and the scope of work includes design, manufacture, supply, testing, & commissioning of 378 metro coaches, supply of spares, and training of personnel. As per the contractual timelines, train deliveries are scheduled to commence from July 2020 until September 2022.

IndiGo’s decision to charge for seats during web check-in under scanner

The Aviation Ministry is all set to look into the issue of airlines like IndiGo and SpiceJet charging for web check-in by asking passengers to pay for selecting their seats. Media reports claimed that the ministry is checking whether this charge falls within the fare unbundling scheme that is followed in India.

As per the fare unbundling rules, the Aviation Ministry allows airlines to charge for things beyond airfares, thus, helping the latter increase revenues.

IndiGo, while responding to a customer’s tweet, had clarified that “as per our revised policy, all seats are chargeable for web check-in. alternatively, you may check-in at the airport for free. Seats will be assigned as per availability".

Ashok Leyland on track to meet 2020 emission norms

Ashok Leyland (ALL), flagship firm of the Hinduja Group, announced that it had achieved its internal milestone for the full range of M&HCV on the road to meeting the BS-VI emission norms.

Dr. N. Saravanan, Senior Vice President, Product Development, Ashok Leyland, said, “We are pleased to share that we have now achieved our internal milestone on emission capability for our entire range of M&HCV vehicles.”

Alembic Pharma JV gets USFDA approval for Lidocaine ointment

Alembic Pharmaceutical’s joint venture (JV) Aleor Dermaceuticals has received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Lidocaine ointment USP, 5%, the company said in a press note to the exchanges on Monday.

The approval had a marginal impact on the company's shares, which were trading 0.5% up.

"The approved ANDA is therapeutically equivalent to the reference-listed drug product (RLD), Xylocaine ointment, 5%, of AstraZeneca Pharmaceuticals LP (AstraZeneca)," the company added in a press note.

 Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More

Share market week key events and data:

F&O expiry, assembly elections, domestic and global macroeconomic data, the trend in global markets, the movement of rupee against the dollar and crude oil price movement will dictate trend on the bourses in the near term. Investment by foreign portfolio investors (FPIs) and domestic institutional investors (DIIs) will be monitored.

Trading could be volatile next week as traders roll over positions in the F&O segment from the near month November 2018 series to December 2018 series. The November 2018 F&O contracts expire on Thursday, 29 November 2018.

On the macro front, the government will announce data on third-quarter gross domestic product (GDP) on 30 November 2018. The Indian economy grew 8.2% year-on-year in the second quarter, above 7.7% in the previous three months.

On the political front, state assembly elections will be closely watched. Assembly elections in Madhya Pradesh and Mizoram will be held on 28 November 2018. Polling in Rajasthan and Telangana will be held on 7 December 2018. The election to the 90-member Chhattisgarh Assembly was held in two phases 12 and 20 November 2018. Counting of votes will be held across all the five states on 11 December 2018.

On the global front, the Markit Composite PMI Flash for November 2018 will be unveiled on 23 November 2018. On the same day, the Markit Manufacturing and Services PMI Flash for November 2018 will be unveiled. The Nikkei Manufacturing PMI Flash for November 2018 will be unveiled on 26 November 2018.

US Federal Reserve's Federal Open Market Committee will release the minutes from its November 7-8 policy meeting on 30 November 2018.

Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More